BioSpace News Archive

Health Canada is advising Canadians that the following products may pose serious health risks.

Veritas Collaborative – a specialty healthcare system focused on the treatment of eating disorders – is blazing a new path in the healthcare industry by partnering with Matchwell.

The Medicrea Group, pioneering the transformation of spinal surgery through artificial Intelligence, predictive modeling and patient specific implants with its UNiD™ ASI proprietary software platform, services and technologies, reports its unaudited results for the first quarter of 2019.

The U. S. District Court ruled today that a Dana-Farber Cancer Institute scientist, Gordon Freeman, PhD, and another scientist, Clive Wood, PhD, are co-inventors on a series of cancer immunotherapy patents previously issued to a Japanese researcher and Japanese drug company, and ordered that the patents be corrected to name Freeman and Wood as inventors.

Eiger BioPharmaceuticals, Inc. announced that David Apelian will step down as the Company’s Chief Operating Officer and Executive Medical Officer, effective June 14, 2019, to become the Chief Executive Officer at a private biotech company.

Kala Pharmaceuticals, Inc., announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2017 Equity Incentive Plan in accordance with NASDAQ Listing Rule 5635.

Aurinia Pharmaceuticals Inc. announced that Mr. Peter Greenleaf, Chief Executive Officer, will present a corporate overview at the RBC Capital Markets Global Healthcare Conference on Wednesday, May 22, 2019 at 6:30am PT (9:30am ET) in New York, NY.

OTC Markets Group Inc. announced Heritage Cannabis Holdings Corp., a company focused on becoming a vertically integrated cannabis provider, has qualified to trade on the OTCQX® Best Market.

In August 2018, the CMS announced that Medicare Advantage plans would be allowed to utilize step therapy for Part B drugs.

Malnati Brain Tumor Institute largest funded grant recipient in Chicago